Skip to content

Dental Stem Cells and Bone Tissue Engineering (CELSORDINO)

Dental Stem Cells and Bone Tissue Engineering

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03194451
Acronym
CELSORDINO
Enrollment
40
Registered
2017-06-21
Start date
2017-07-10
Completion date
2019-07-10
Last updated
2017-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth, Impacted

Keywords

bone tissue engineering, dental stem cell differentiation

Brief summary

The main limitation in bone regeneration is the lack of vascularization of the newly shaped tissue. The main objective of this project is to check if the simultaneous differentiation of dental mesenchymal stem cells toward osteoblastic and endothelial lineage permits to obtain a new pre-vascularized tissue engineered bone construct. We will then evaluate the boosting effect of the conditionned medium on cell differentiation and production of a prevascularized bone construct.

Detailed description

This project aims to develop a new pre-vascularized tissue engineered bone construct, using human cells of a simple and non invasive tissue source: dental pulp. We will isolate mesenchymal stem cells from dental tissue of wisdom teeth, extracted from patients aged between 13 and 17 years old. The objectives are: (i) to assess in combination the endothelial differentiation and osteoblastic differentiation of dental pulp stem cells (immature third molar); (ii) to study the boosting effect of the conditionned medium on cell differentiation and production of a prevascularized bone construct. The differentiation will be monitored by evaluation of biosynthesized matrix, bone mineralization (immunohistochimie, Westen Blot), histological response (Von Kossa, Alizarin Red) and presence and quantification of pseudo-vascular structures (angiogenesis assay), compared to reference value (commercial differentiation medium).

Interventions

OTHERnon-interventional study

teeth collection

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* patients aged between 13 and 17 years, who will come to Dental Service of University Regional Hospital Center of Nancy in order to have a tooth avulsion. * patient who has received a complete information about research organization and who is not opposed to the use of his own data. * patient who the representatives of parental authority have received a complete information about research organization and who are not opposed to the use of children's data.

Exclusion criteria

* patients with local or general pathology

Design outcomes

Primary

MeasureTime frameDescription
Bone mineralizationDay 28 of cell cultureMeasured parameter is equal or superior to reference value (commercial differentiation medium)

Secondary

MeasureTime frameDescription
presence and quantification of pseudo-vascular structuresDay 28 of cell cultureMeasured parameter is equal or superior to reference value (commercial differentiation medium)

Contacts

Primary ContactVanessa MOBY, DD, PhD
vanessa.moby@univ-lorraine.fr0383154256

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026